For Immediate Release

Chicago, IL – October 15, 2009 – Zacks Equity Research highlights Sangamo Biosciences, Inc. (SGMO) as the Bull of the Day and Conmed (CNMD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Intel Corp. (INTC), JPMorgan Chase & Company (JPM) and CSX Corp. (CSX).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676

Here is a synopsis of all five stocks:

Bull of the Day:

Sangamo Biosciences, Inc. (SGMO) uses a proprietary ZFP gene regulation technology to discover and develop a new class of therapeutic candidates for diabetic neuropathy, cardiovascular disease, cancer and immune diseases.

We are optimistic about this novel technology. SB-509 has shown some positive results for the treatment of moderate to severe DN. We are also optimistic about other clinical programs. Further, we are impressed by the company's strategy

...

CSX Corp. (CSX) reported earnings from continuing operations of $293 million or 74 cents per share, ahead of the Zacks Consensus Estimate of 71 cents per share. Earnings were down $380 million or 93 cents per share in the prior year period. The decline was brought about by lower revenues, partially offset by reduced expenses. Revenue for the period fell 23% to $2.3 billion due to significant declines in both volume and fuel recovery. However, management said that core pricing momentum has remained intact. CSX Corp. witnessed a 15% decline in volume during the quarter, led by a decline in shipments of coal, cars, construction and consumer goods. Coal, which brings a major portion of the company’s revenue, has declined due to lower global demand. It has suffered due to low demand, high inventories and low gas prices. Going further, management expects both domestic ...

CSX Corp. (CSX), the first railroad to report earnings this quarter, posted diluted EPS from continuing operations of $0.72. This compares to consensus of $0.62 and our estimate of $0.70. This good performance largely reflected strong cost-control as revenues fell sharply during the quarter and were below our estimate. Total revenues declined 25% to $2,185 million from $2,907 million on a 21% drop in volume as almost all businesses experienced larges declines, with the worst performances in metals, coke and iron ore, automotive and international intermodal. Moreover, a $223 million drop in fuel surcharge recovery also contributed to lower revenues. Revenue per unit witnessed a 5% falloff as all segments reported decreases, except chemicals (up 1%) and coal (up 2%). Operating expenses fell 27% year over year to $1,603 million as most line items posted declines related to weaker business volumes, cost management programs, and ...

Six Dow components are scheduled to report as large-cap stocks dominate the first big week of earnings season. The 6 companies are Bank of America (...

For Immediate Release

Chicago, IL - April 17, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Biogen Idec (BIIB), CSX Corp (CSX), Infosys Technologies (INFY), Kimberly-Clark Corp (KMB) and Procter & Gamble (PG).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Thursday's Analyst Blog:

Biogen Beats on Bottom-Line

Biogen Idec (BIIB) reported financial results for the first quarter ended March 31, 2009 on April 16, 2009. Revenues for the quarter totaled 1,036.5 million, up approximately 10% from the same period in 2008, and just below our forecast of $1,075 million.

Revenues were

...

The Light is Real… and it’s not a Train

by The Investment U Research Team

This morning, Wells Fargo & Co. (NYSE: WFC) announced that it expects a $3 billion profit from the first quarter. One of the biggest banks in the country, Wells Fargo is the first big winner from this earnings season.

It’s in stark contrast to Alcoa (NYSE: AA), the world’s biggest aluminum producer, which reported lower earnings than expected.

Wells Fargo’s news has spurred a mini rally this morning, and traders are rushing back into financials. But it shouldn’t surprise anyone, really.

It’s a huge clue that there are large profits being made – the world hasn’t ended.

No doubt, there will be firms that are so severely affected by this downturn that they will have no choice but

...

Based on the investor poll, commodities seem to be the most appealing investment for 2009. Followed by stocks, bonds and cash as the worst asset class for the year. In this post I would like to gather opinions about investing in 2009 from top investor gurus. Let me start with Warren Buffett. Warren called stock market bottom already in mid 2008 and have started to add equity positions to his holding. Last actions show buying interests in railroads companies. He increased stake in Burlington Northern (BNI). Despite of declining volume, earnings have gone up by 19%. Other interesting picks from industry are Union Pacific with 35% earnings growth or CSX Corp (CSX) with 16%. Another two top investors, Donald Coxe and David Winters, like railroads. Companies will benefit from low energy costs. P/E vary in range of 6 - 8 for the ...

NetScout Systems, Inc. (

...

We are continuing our Buy rating on CSX Corporation (CSX), a provider of rail freight and intermodal transportation, but lowering our target price to $40. CSX will report fourth quarter results on January 20.We are reducing our diluted EPS estimates to $3.60 from $3.66 for 2008, below CSX guidance of $3.65-3.75, and to $3.75 from $4.25 for 2009, largely due to lower revenue estimates related to weakening volumes from a slowing economy and reduced fuel surcharge revenues.Partial offsets include improved efficiency, better yields, and share buybacks. CSX posted third quarter EPS of $0.94, above the $0.93 consensus, but below our $0.97 estimate, due to storm-related losses in the Gulf Coast and the Midwest.CSX's growth prospects still look solid, with management affirming long-term growth estimates (through 2010) of 15-20% in operating income and of 20-25% in EPS, partly reflecting improved efficiency, with the ...

We make mention of the following companies: Altria (MO), Biogen Idec (BIIB), CSX Corp. (CSX), Exxon (XOM), Johnson & Johnson (JNJ) and General Electric (GE).Below are two graphs tracking the behavior of different long-term interest rates over time -- now vs. the late 1920s and early '30's. Changes in the spreads between bonds of similar durations are due to the market's perception of the relative likelihood of default, from securities with very-little-or-no-probability of default like Treasuries having lower yields to things like junk bonds with a high likelihood of default.Since the long-term government securities is a discontinued series, and the 20-year constant maturity series does not go back that far, the comparisons are not exact, but are reasonably close. This is monthly data for both time periods (only data available for the 1930's).If daily values were shown ...